Skip to content

Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism

Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02005250
Enrollment
93
Registered
2013-12-09
Start date
2012-02-29
Completion date
2020-01-01
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism, Hypothyroidism

Keywords

osteoporosis, hyperthyroidism, hypothyroidism

Brief summary

The aim to evaluate the bone structure by Dexa-scan, extreme CT and bone markers before and one year after treatment for a thyroid functional disorder

Detailed description

The aim to evaluate the bone structure by Dexa-scan, extreme CT and bone markers before and one year after treatment for a thyroid functional disorder. Women with hyper- og hypothyroidism are included and undergo usual treatment. Patients are stratified into 10 different groups.

Interventions

None listed

Sponsors

Steen Bonnema
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

informed consent, female sex, age 20-85 years, indication for treatment of the thyroid disorder,

Exclusion criteria

pregnancy, renal insufficiency, known osteoporosis, other disease that may affect bone metabolism, medication which affects bone metabolism, T-score below -3.5, thyroidea ophthalmopathy with indication for steroids,

Design outcomes

Primary

MeasureTime frameDescription
Thyroid Extreme CTone yearBone cortical thickness in the radius measured by high-resolution peripheral quantitative CT, in newly diagnosed thyroid disorder, before and after treatment aimed to obtain euthyroidism

Countries

Denmark

Participant flow

Recruitment details

Patients are enrolled consecutively, until maximum 200 participants are reached, or further enrollment is terminated on the decision by the sponsor.

Participants by arm

ArmCount
Hyperthyroidism
46 women with Graves' disease, toxic nodular goiter or subclinical hyperthyroidism
46
Hypothyroidism
27 women with overt or subclinical autoimmune hypothyroidism
27
Total73

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up155

Baseline characteristics

CharacteristicHyperthyroidismHypothyroidismTotal
Age, Continuous55.83 years
STANDARD_DEVIATION 11.47
48.3 years
STANDARD_DEVIATION 11.3
53 years
STANDARD_DEVIATION 9
Cortical thickness0.74 mm1.15 mm0.90 mm
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Denmark
46 Participants27 Participants73 Participants
Sex: Female, Male
Female
46 Participants27 Participants73 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 460 / 27
other
Total, other adverse events
0 / 460 / 27
serious
Total, serious adverse events
0 / 460 / 27

Outcome results

Primary

Thyroid Extreme CT

Bone cortical thickness in the radius measured by high-resolution peripheral quantitative CT, in newly diagnosed thyroid disorder, before and after treatment aimed to obtain euthyroidism

Time frame: one year

ArmMeasureValue (MEDIAN)
HyperthyroidismThyroid Extreme CT0.89 mm
HypothyroidismThyroid Extreme CT1.16 mm

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026